The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Circular Economy Action Plan by EC has identified up to 80% of products environmental impacts are determined at the design phase, which highlights the importance of embedding circularity in pharmaceutical research and development. Sustainability by Design (SbD) is a program that integrates sustainability in the product development processes and uses life cycle assessment data and eco-design principles to inform design choices that minimize environmental impact of products including reduced carbon footprint, reduced use of resources, pollution prevention, controls for human health and environmental impacts, and improved circularity potential.